Eli Lilly
22 pharma companies join forces for global non-communicable disease initiative
January 18, 2017Research and Development BMS, Celgene, Eisai, Eli Lilly, GSK, J&J, JJ, MSD, Merck, Novartis, Pfizer, Roche, Sanofi, Takeda
The World Economic Forum Annual Meeting in Switzerland has seen the launch of Access Accelerated, a global initiative consisting of …
Lilly three strikes in three years not out in Teva patent challenge
January 13, 2017Medical Communications, Sales and Marketing Eli Lilly, Teva, generics, lilly, patent
Eli Lilly has successfully won a major patent case against Teva Pharmaceuticals, with the case being decided at the US …
MSD and Lilly announce immuno-oncology collaboration
January 11, 2017Medical Communications, Research and Development Eli Lilly, Lartruvo, MSD, keytruda, lilly
MSD, known as Merck in North America, and Eli Lilly have announced the expansion of their existing immuno-oncology collaboration. The …
New formulary ‘bank’ to aid research into combination therapies
January 11, 2017Medical Communications, Research and Development 21st Century Cures Act, Bristol-Myers Squibb, Eli Lilly, Joe Biden, Obama, bristol myers-squibb, combination therapy
As part of the wider ‘cancer moonshot’ initiative, confirmed by the signing of the 21st Century Cures Act by Obama, …
Five major pharma firms break ABPI code of conduct, according to watchdog
December 15, 2016Medical Communications, Sales and Marketing ABPI, AstraZeneca, Boehringer Ingelheim, Eli Lilly, Grunenthal, Janssen
Eli Lilly, Boehgringer Ingelheim, AstraZeneca UK, Grunenthal and Janssen-Cilag have been “named and shamed” by the Prescription Medicines Code of …
Lilly offers insulin at 40% discount
December 13, 2016Research and Development, Sales and Marketing Blink Health, Eli Lilly
Eli Lilly has announced that it will offer its insulin medication, including Humalog, at a 40% discount for eligible patients …
FDA approves another indication for Lilly/Boehringer diabetes treatment
December 5, 2016Sales and Marketing Boehringer Ingelheim, Eli Lilly, FDA, jardiance
Jardiance (empagliflozin), an oral SGLT02 inhibitor developed by Eli Lilly and distributed by Boehringer Ingelheim, has been approved by the …
Lilly forced to abandon Alzheimer’s drug after failed trial
November 24, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alzheimer's, Alzheimer's disease, Eli Lilly
Eli Lilly announced that the results of its ‘Expedition 3’ trial for an experimental Alzheimer’s disease drug meant that they would …
Eli Lilly gains accelerated approval from FDA for soft tissue sarcoma drug
October 20, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eli Lilly, FDA, US, soft tissue sarcoma
Eli Lilly received the positive news that their drug, Lartruvo, has been granted accelerated approval for use in conjunction with …
Lilly announces plan to expand global access to health care
October 19, 2016Research and Development Eli Lilly, Lilly 30x30, global health
Eli Lilly has announced a project, known as Lilly 30×30, which is a five-year, $90 million investment to improve access …
Novartis’ new drug muscles in on Pfizer’s territory
October 10, 2016Sales and Marketing Eli Lilly, Novartis, Pfizer, ibrance, ribociclib
A drug developed by Novartis, ribociclib, when combined with an older drug, letrozole, has been shown to reduce risk of progression …
EU recommendation for Lilly’s soft tissue cancer drug
September 19, 2016Sales and Marketing CHMP, EMA, Eli Lilly, Lartruvo, soft tissue sarcoma
The Committee for Medicinal Products for Human Use (CHMP) has recommended Eli Lilly’s Lartruvo (olaratumab) for treatment of adults with …
Levi Garraway to succeed Richard Gaynor as senior VP of Global Oncology at Lilly
September 15, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eli Lilly, appointment
Eli Lilly has announced that Dr Levi Garraway will join the company as its senior vice president, Global Development & …
Eli Lilly elects Jamere Jackson to board of directors
September 1, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eli Lilly, appointment
Eli Lilly has elected Jamere Jackson to its board of directors, effective 1 October, where he will serve on the …
New senior VP, finance at Eli Lilly
August 10, 2016Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eli Lilly
Eli Lilly has announced that Joshua Smiley is set to become senior vice president, finance, and treasurer from October 1, …
Latest content
Five Facts about cardiovascular disease
Artificial hearts: a century of innovation
